show episodes
 
Join Mark E. Molitch, MD, as he discusses treatment goals and target blood pressures for patients with hypertension in the setting of Type 2 diabetes. He also reviews the cardiovascular and renal endpoints in several trials, and describes combination therapies for achieving blood pressure control in these patients.
 
The goal of this activity is to provide up-to-date information and multiple perspectives on the evolving pathogenesis, symptoms, risk factors, and complications of T2DM as well as current and emerging treatments and best practices in the management of patients with T2DM.
 
A number of organizations have issued guidelines or statements addressing the diagnosis and management of type 2 diabetes mellitus (T2DM). Although these statements share many common features, they differ in some key aspects. In this podcast, Jaime A. Davidson, MD, addresses some of the differences between these guidelines, and offers a number of important insights into their practical implementation.
 
Hemoglobin A1 (HbA1c) measurement is widely used in the management of type 2 diabetes mellitus (T2DM). However, expert consensus and professional guidelines conflict as to the correct use of this tool for diagnosis and therapeutic decision-making. In this podcast, Zachary Bloomgarden, MD, argues that a "one-size-fits-all" approach to interpretation and use of HbA1c is inherently flawed. He discusses the reasons and strategies for individualizing treatment goals and HbA1c targets in patients ...
 
The Beta Cells in Diabetes podcast seeks to improve understanding among primary care physicians about the role of beta cells as key drivers in the development and progression of T2DM. Our goal is to engage primary care physicians in pathopysiology-based clinical decision making through an interactive educational format that stimulates debate and encourages physicians to incorporate the new science into their patient treatment regimens. By educating primary care physicians about the newest fi ...
 
Loading …
show series
 
This week on The Rounds Table we’re back by popular demand with another rapid fire episode: just the salient points from FOUR articles instead of two. Same time spent listening, twice the take-home! Kieran Quinn and Mike Fralick tease out the bottom line for listeners. Both hyperglycemia and hypoglycemia are prevalent, real, concerns for patien ...…
 
SHR # 2017 :: CASUAL FRIDAY :: Alisa Profumo - Carl Lanore :: The Mexico Effect - I'll Have A Bat and Spring Mix Salad - Famous Vegetarian/Vegan Couples - The Amazing Avocado - Canine Cancer Detectors - Are You A Pigeon - The Replacement for BPA is Worse ... And Carl Predicted It - Childhood Diabetes Continues to Rise - T2DM and Gum Disease - E ...…
 
SHR # 2010 :: CASUAL FRIDAY :: Alisa Profumo - Carl Lanore :: Hippocrates Speaks To Us Today - Climate Change Blamed for T2DM - Mainstream Misinformation: Oral Contraception - California Strikes a Blow to Glyphosate - Brazilian Meat Scandal - Paleoair: Really!? - Plus More ::
 
SHR # 2010 :: CASUAL FRIDAY :: Alisa Profumo - Carl Lanore :: Hippocrates Speaks To Us Today - Climate Change Blamed for T2DM - Mainstream Misinformation: Oral Contraception - California Strikes a Blow to Glyphosate - Brazilian Meat Scandal - Paleoair: Really!? - Plus More ::
 
Diabetes is a BIG Deal! As I was getting ready to record this podcast, I looked at the updated statistics for diabetes in Canada and in the US. In Canada, 11 million individuals, or 29% of the population has some type of diabetes! In the US, 29.1 million or 9.3% of the population has diabetes! These are HUGE numbers. It is not only the diagnosi ...…
 
SHR # 2003 :: SuppVersity Science Roundup: Is There Mercury in Whey Protein - Exogenous Insulin Prevents T2DM Cure - Non-Nutritive Sweeteners Increases Appetite for Sweets - Possible SIBO Recovery Without Antibiotics :: Adel Moussa :: Four topics of great interest are covered by the brilliant Adel Moussa ::…
 
Please enjoy this encore presentation of 2 Keto Dudes from August 16th, 2016. Mad As Hell. Carl Franklin and Richard Morris get angry about how the medical establishment hasn't evolved along with science. We KNOW the chain of events that leads to type 2 diabetes (T2DM). Not only do we KNOW how to reverse it, but we knew in the 70's! Why after a ...…
 
“You can’t really start making strides forward until you start telling yourself that maybe [having Type 1 Diabetes] makes you stronger, or maybe you wouldn’t be the person you are [without it]. Looking back on 13 years of diabetes, I … Continued The post 46 – Living and training with Type 1 Diabetes with Brendan Snyder appeared first on Julie F ...…
 
“You can’t really start making strides forward until you start telling yourself that maybe [having Type 1 Diabetes] makes you stronger, or maybe you wouldn’t be the person you are [without it]. Looking back on 13 years of diabetes, I … Continued The post 46 – Living and training with Type 1 Diabetes with Brendan Snyder appeared first on Julie F ...…
 
Sponsor: You can support EP when you shop online! Simply open Amazon via enduranceplanet.com to do your online shopping—it’s just one extra click to link to Amazon through the banner on our sidebar or click theAmazon links in the show notes. We are back with Dr. Tommy Wood for another edition of Ask the Doc. Three major areas covered in this ep ...…
 
This week, Carl Franklin and Richard Morris get angry about how the medical establishment hasn't evolved along with science. We KNOW the chain of events that leads to type 2 diabetes (T2DM). Not only do we KNOW how to reverse it, but we knew in the 70's! Why after all this are most doctors still clueless about how to treat it? Richard tells the ...…
 
Management of Persistent Hyperglycemia in T2DM: Beyond Starting Doses of Basal Insulin
 
Management of Persistent Hyperglycemia in T2DM: Beyond Starting Doses of Basal Insulin
 
Basal Insulin and Beyond: Management of Persistent Hyperglycemia in T2DM
 
Basal Insulin and Beyond: Management of Persistent Hyperglycemia in T2DM
 
Dr. Jason Fung is a Consultant Nephrologist who trained and began his medical career at the University of Toronto before heading to the University of California in Los Angeles where he completed his fellowship in nephrology. Since then he has founded the Intensive Dietary Management Program, which provides a unique treatment for Type 2 Diabetes ...…
 
In this episode 001 I review: BODY WHAT IS OBESITY: Obesity is a complicated chronic disease of energy imbalance where energy consumed (calories) is greater than energy expended (Calories burned) which results in excess body fat storage. Obesity is NOT simply a lifestyle or behavioral choice. Obesity is the result of complicated interplay betwe ...…
 
Doron Schneider, MD and Jack Leahy, MD discuss the pros and cons of combination therapy for as initial treatment. (17:40)
 
Dr. Henry continues his discussion by giving an overview of classes of pharmacologic therapies, and their effects on different blood lipids. He also reviews key recommendations from guidelines regarding the treatment of dyslipidemia, reviews key clinical trials, and provides up-to-date information on recent and ongoing trials.…
 
In this segment, Robert Henry, MD, discusses risk factors related to blood lipids, predictors of risk beyond LDL-C, recommendations for lipid levels, and customizing goals for therapy, in patients with type 2 diabetes.
 
Dr. Molitch discusses combination therapies for achieving blood pressure control in patients with hypertension in the setting of Type 2 diabetes.
 
Dr. Molitch discusses treatment goals and target blood pressures for patients with hypertension in the setting of Type 2 diabetes. He also reviews the cardiovascular and renal endpoints in several trials.
 
Jaime A. Davidson, MD, discusses guidelines and statements issued by a number of organizations, including the American Diabetes Association (ADA), addressing the diagnosis of type 2 diabetes mellitus (T2DM) and how they differ in some key aspects.
 
Google login Twitter login Classic login